Mawer Investment Management Ltd. Has $192.83 Million Stock Position in Waters Co. (NYSE:WAT)

Mawer Investment Management Ltd. trimmed its stake in Waters Co. (NYSE:WAT - Free Report) by 2.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 519,776 shares of the medical instruments supplier's stock after selling 11,856 shares during the period. Mawer Investment Management Ltd. owned approximately 0.88% of Waters worth $192,826,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the stock. Vanguard Group Inc. grew its position in Waters by 0.3% during the 4th quarter. Vanguard Group Inc. now owns 7,098,668 shares of the medical instruments supplier's stock worth $2,633,464,000 after purchasing an additional 19,456 shares during the last quarter. Wealthfront Advisers LLC raised its stake in shares of Waters by 106,144.4% during the 4th quarter. Wealthfront Advisers LLC now owns 3,087,461 shares of the medical instruments supplier's stock worth $1,145,386,000 after buying an additional 3,084,555 shares in the last quarter. State Street Corp boosted its stake in shares of Waters by 1.9% in the third quarter. State Street Corp now owns 2,577,733 shares of the medical instruments supplier's stock valued at $927,700,000 after buying an additional 49,194 shares in the last quarter. Geode Capital Management LLC grew its holdings in Waters by 1.2% during the third quarter. Geode Capital Management LLC now owns 1,416,683 shares of the medical instruments supplier's stock worth $508,123,000 after acquiring an additional 16,703 shares during the period. Finally, Janus Henderson Group PLC raised its position in Waters by 0.7% in the third quarter. Janus Henderson Group PLC now owns 885,593 shares of the medical instruments supplier's stock worth $318,717,000 after acquiring an additional 6,256 shares in the last quarter. Institutional investors and hedge funds own 94.01% of the company's stock.

Remove Ads

Waters Stock Down 3.6 %

Shares of Waters stock traded down $13.14 on Tuesday, hitting $355.43. 560,995 shares of the company traded hands, compared to its average volume of 456,015. The company has a 50-day moving average price of $385.54 and a 200 day moving average price of $373.45. The company has a quick ratio of 0.65, a current ratio of 0.94 and a debt-to-equity ratio of 1.14. Waters Co. has a 12-month low of $279.24 and a 12-month high of $423.56. The company has a market cap of $21.12 billion, a PE ratio of 33.19, a PEG ratio of 3.79 and a beta of 1.00.

Waters (NYSE:WAT - Get Free Report) last posted its earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 EPS for the quarter, topping the consensus estimate of $4.02 by $0.08. Waters had a net margin of 21.56% and a return on equity of 46.31%. Sell-side analysts predict that Waters Co. will post 12.86 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on WAT. Sanford C. Bernstein upgraded Waters from a "market perform" rating to an "outperform" rating and set a $430.00 price target on the stock in a report on Friday, January 10th. KeyCorp upgraded Waters from a "sector weight" rating to an "overweight" rating and set a $460.00 target price on the stock in a report on Monday. Bank of America reduced their price objective on Waters from $430.00 to $410.00 and set a "neutral" rating on the stock in a research report on Thursday, February 13th. Scotiabank upgraded Waters from a "sector perform" rating to a "sector outperform" rating and lifted their price objective for the stock from $430.00 to $450.00 in a research report on Thursday, February 13th. Finally, Barclays upgraded shares of Waters from an "underweight" rating to an "equal weight" rating and upped their target price for the company from $360.00 to $415.00 in a report on Monday, February 10th. Ten equities research analysts have rated the stock with a hold rating, seven have assigned a buy rating and two have issued a strong buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $401.31.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.